Filing Details

Accession Number:
0001209191-16-117954
Form Type:
4
Zero Holdings:
No
Publication Time:
2016-05-05 20:26:18
Reporting Period:
2016-05-04
Filing Date:
2016-05-05
Accepted Time:
2016-05-05 20:26:18
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1044378 Biocept Inc BIOC Services-Medical Laboratories (8071) 330757995
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1598736 Claire Reiss C/O Biocept, Inc.
5810 Nancy Ridge Drive #150
San Diego CA 92121
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2016-05-04 614,273 $1.00 2,458,016 No 4 P Indirect By trusts
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect By trusts
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Warrant to Purchase Common Stock Acquisiton 2016-05-04 429,991 $0.00 429,991 $1.30
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
429,991 2016-05-04 2021-05-04 No 4 P Indirect
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 14,012 Indirect by corporation
Footnotes
  1. Shares were purchased from the issuer in a unit offering, with each unit consisting of one share of Common Stock and one warrant to purchase .70 shares of Common Stock for $1.00 per unit.